Cookie Notice

This site uses cookies. By continuing to browse this site, you are agreeing to our use of cookies. Review our cookies information for more details.

skip to main content

Artificial Intelligence for early image diagnosis of SJS/TEN

Published: September 18, 202

Stevens–Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN) is a life-threatening cutaneous adverse drug reaction (cADR). However, it is difficult to distinguish SJS/TEN from non-severe cADRS, especially in the early stages of the diseases.

In an original article in The Journal of Allergy and Clinical Immunology: In Practice, Fujimoto et al. trained a deep convolutional neural network (DCNN) using a dataset of 26,661 individual lesion images obtained from 123 patients diagnosed with SJS/TEN or non-severe cADRs. The DCNN’s classification accuracy was compared to that of 10 board-certified dermatologists and 24 trainee dermatologists.

The DCNN achieved 84.6% sensitivity, whereas the sensitivities of the board-certified dermatologists and the trainee dermatologists were 31.3 % and 27.8%, respectively. The negative predictive value was 94.6% for the DCNN, 68.1 % for the board-certified dermatologists, and 67.4% for the trainee dermatologists. The area under the receiver operating characteristic curve of the DCNN for SJS/TEN diagnosis was 0.873, which was significantly higher than that of all the board-certified dermatologists and trainee dermatologists.

In conclusion, the DCNN demonstrated superior performance in screening for SJS/TEN compared with dermatologists. Along with clinical information, the DCNN may, as a diagnostic test, provide useful supportive data for a comprehensive diagnosis.

The Journal of Allergy and Clinical Immunology: In Practice is an official journal of the AAAAI, focusing on practical information for the practicing clinician.

Full Article